Colonic Perforation After Treatment With Nivolumab in Esophageal Cancer: A Case Report

With the advent of checkpoint inhibitors, it has opened up opportunities for numerous cancer patients. However, as is the case with every treatment, complications need to be weighed. Gastrointestinal adverse effects, such as diarrhea and colitis are well-known complications for checkpoint inhibitors...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hye Jung Cho, Woo Ram Kim, Joo-Hang Kim, Duk Hwan Kim, Dae Jung Kim, Haeyoun Kang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Korean Society of Coloproctology 2021-07-01
Edice:	Annals of Coloproctology
Témata:	nivolumab intestinal perforation drug-related side effects and adverse reactions immunotherapy
On-line přístup:	http://coloproctol.org/upload/pdf/ac-2020-00213-0030.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!